RNAC vs TYL · P/E 2.1, rev $78.0K vs P/E 89, rev $1.26B
Cartesian Therapeutics Inc. (RNAC) versus Tyler Technologies Inc (TYL) — a side-by-side from cached financials, not a winner call.
Cartesian Therapeutics Inc. (RNAC) is a biotechnology company listed on US.
Tyler Technologies Inc (TYL) is a software - application company listed on US.
Latest reported RNAC revenue for 2026-06-30 was $78.0K. Net income was -$23.4M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. RNAC currently screens at market cap $290.9M and trailing P/E 2.1.
Latest reported TYL revenue for 2026-06-30 was $1.26B. Net income was $174.7M. TYL currently screens at market cap $25.57B and trailing P/E 89.3.
RNAC currently screens at market cap $290.9M and trailing P/E 2.1. TYL currently screens at market cap $25.57B and trailing P/E 89.3.
Not investment advice. Open the RNAC and TYL stock pages for the full models.
Not investment advice.